Molekule Tackles the $18 Billion U.S. Allergy Market at Its Source with First-Ever Allergen-Destroying Technology

Molekule, the company behind the only air purifier proven to destroy air pollutants, is leveraging its patented technology to tackle the $18 billion allergy treatment market this year. Designed specifically with asthmatics and allergy sufferers in mind, Molekule is scientifically proven to eliminate the pollutants that cause common allergy symptoms. For the 50 million Americans suffering from asthma and allergies every year, Molekule’s new approach could be life-changing -- and it could not come at a better time.
 
According to the Asthma and Allergy Foundation of America, allergies affect almost 1 in 4 Americans -- and this number is only growing. Climate change is increasing allergens in the air, causing worsened symptoms year-over-year and adding to the billions Americans spend yearly on allergy medication and doctor’s visits in pursuit of a sneeze-free spring. What’s worse, all of that money is being spent on treatments that are largely ineffective. Not only do allergy medications carry a slew of adverse side effects, but they, at-best, only mask symptoms. Controlling the source of allergens is a critical step to reducing allergic response. Source control includes regular vacuuming, hypoallergenic sheets and pillowcases, minimizing carpet, and air filtration.
 
For decades, the limitations of air purification technology have made true source control impossible.  Even the most premium, HEPA-certified air filters can only do so much: in fact, HEPA’s World War II-era tech solely collects particulates and can even allow allergy-exacerbating pollutants like mold to live and breed on the filter, making the initial problem worse. Unlike all other air purifiers to date, Molekule’s Photo Electrochemical Oxidation (PECO) technology does not just capture, but completely destroys the full spectrum of indoor pollutants, including those 1000x smaller than a HEPA filter can catch.
 
Molekule’s Chief Scientist and Co-Founder, Dr. Yogi Goswami, was witness to his own son’s debilitating asthma and allergies and saw first-hand the devastating effect they can have. Spurred by his frustration with existing pharmaceutical and air filtering solutions, he dove headfirst into finding an effective remedy for his son’s suffering. A renewable energy expert, Goswami leveraged his expertise to invent Molekule’s PECO technology and bring real relief to asthma and allergy sufferers.
 
In addition to third-party tests and personal experience to verify the efficacy of the technology, Molekule has also completed a review of its 49-person IRB approved beta study program, including people with severe nasal and ocular allergy symptoms. Findings have shown that allergy sufferers experience dramatic, statistically significant (p-value less than 0.0001), sustained symptom reduction within a week of use. These results were presented at the ACAAI Annual Conference 2017.
 
“Of course, blooming trees and walks around the city can exacerbate your allergies; but when these allergens follow you home--and they will--your body is robbed of the time it needs to rest and recover, meaning you wake up feeling even worse,” says Jaya Rao, COO of Molekule. “With Molekule, you can offer yourself that room to breathe and allow your body recuperate, even in the thick of allergy season.”
 
Launched to consumers in July 2017 after raising $10.1M in Series A funding, Molekule was named one of TIME Magazine’s Best Inventions of 2017. Integrating foundational science, software, and hardware, Molekule now retails at $799.00, with filters automatically mailed to consumers on an annual subscription basis for $129.00. Molekule’s immense popularity caused it to completely sell out over the holiday season. Now, it is back in stock -- just in time to bring much-needed relief this allergy season.
 
To learn more about Molekule and order your own today, visit Molekule.com.
 
About Molekule:
Molekule is a science and clean technology company whose goal is the elimination of indoor air pollution for everyone, everywhere. Molekule created the world’s first molecular air purifier, capable of destroying all indoor air pollutants and eliminating the symptoms they cause. Founded in 2014, Molekule is headquartered in San Francisco. For more information, visit: www.molekule.com.  
 

Contact Information

Lauren Volkmann

Account Manager

VSC/Wareness for Molekule

lv@vscconsulting.com